“Unfortunately, we are not strong when it comes to conducting clinical trials”

The number of company-initiated clinical trials conducted in Sweden has been declining in recent years. In mid-March, a government inquiry was presented that ai...

Did you know that not every sphere is really a round sphere?

ZEISS Metrology Expert Tip.

About Microscope Ergonomics

Learn about ergonomic microscope design and how you can increase your well-being and productivity when working in clinical microscopy. Read about challenges, de...

Oasmia tar in 151 miljoner – och byter namn

Styrelsen i cancerforskningsföretaget Oasmia har beslutat om en nyemission på 151 miljoner kronor. Samtidigt föreslås ett namnbyte av företaget till Vivesto.

Microscope and measuring machine in one

ZEISS O-INSPECT duo covers two essential applications in quality assurance.

Karin Almqvist Liwendahl blir ny finanschef på Dignitana

Medicinteknikbolaget Dignitana har värvat Karin Almqvist Liwendahl som ny finanschef.

Beta-blockers are often given unnecessarily, a study finds – “This will affect future practice”

Patients who have suffered a minor heart attack do not benefit from beta-blockers, according to a major new study that may change guidelines for cardiac care.

Novavax is developing a vaccine candidate against Covid-19 and seasonal flu

A combined vaccine against both Covid-19 and seasonal flu is showing promising results in studies, according to the American drug developer Novavax. The adjuvan...

Recipharm divests five Swedish plants

Swedish contract manufacturer Recipharm is selling its facilities in Solna, Strängnäs, Höganäs, Karlskoga and Uppsala OTC Development to US private equity compa...

Stor oro i branschen efter ryska invasionen: "Kommer att påverka oss alla"

Den svenska life science-branschen reagerar med bestörtning och oro på Rysslands invasion av grannlandet Ukraina. Nu kartläggs hur stora konsekvenserna blir för...

Study: Popular diabetes treatment is not associated with thyroid cancer

Concerns raised about an association between GLP-1 analogues, used to treat diabetes and obesity, and an increased risk of thyroid cancer are not supported by a...

A growing industry in Denmark: “One new life science company a week”

The life science sector in eastern Denmark continues to grow in the number of employees, as well as the number of companies. An emerging problem is the shortage of labour, a new...

Kvinnan bakom Novo Nordisks fetmasuccé: ”Slutade aldrig tro på GLP-1”

Det tog flera år av misslyckanden inom GLP-1 innan Lotte Bjerre Knudsen och hennes kollegor hittade rätt – men då var det en riktig fullträff. ”Vi investerade i...

40,000 DNA extractions daily

It's great when things run quickly: 20 minutes per extraction process and a new plate every 2.5 minutes – the Dutch company Synchron Lab Automation, in cooperat...

An easy way to handle microtiter plate stacks

Do you want to automate handling of microtiter plates.? Have a look at a very simple solution on how to handle them.

Study: Our behaviour may have been guided by wishful thinking during the pandemic

A new study suggests that we systematically underestimate health risks if and when it suits us. This was especially true during the pandemic, as our risk assess...

A+ Science AB

Energibesparing med Wilden

Wildens unika och patenterade luftsystem Pro-Flo Shift® ger upp till 60% besparing av drivluft.

High-performance Slide Scanner for Fluorescence, Brightfield and Polarization

ZEISS Axioscan 7.

Søren Bregenholt omvald som ordförande i MVA

Under Medicon Valley Alliance årsstämma fick styrelsen förnyat förtroende och valdes om.

A new international stem cell research centre has been created in Copenhagen

A new centre for stem cell research opened to the public in January. The Novo Nordisk Foundation backs the initiative with the ambition that the centre will advance new medical technology and ...

New issue of Life Science Sweden!

The international issue of Life Science Sweden has been sent to press.

Donanemab godkänns i Storbritannien – men anses för dyrt för skattebetalarna

Eli Lillys alzheimerläkemedel donanemab godkänns i Storbritannien – men lär ändå inte bli tillgängligt för vanliga patienter. Orsaken är att behandlingen bedöms...

Första bekräftade dödsfallet i omikron i Storbritannien

Minst en person har dött i omikronvarianten i Storbritannien. Det uppger premiärminister Boris Johnson.